IEQ Capital’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-303,816
Closed -$30.9M 1949
2025
Q4
$30.9M Buy
303,816
+183,266
+152% +$14.7M 0.09% 130
2025
Q3
$6.6M Sell
120,550
-1,027
-0.8% -$51.3K 0.02% 420
2025
Q2
$6.46M Buy
121,577
+76,292
+168% +$3.88M 0.04% 354
2025
Q1
$1.96M Buy
45,285
+18,292
+68% +$926K 0.02% 592
2024
Q4
$1.52M Buy
26,993
+22,222
+466% +$1.38M 0.01% 573
2024
Q3
$325K Buy
+4,771
New +$269K ﹤0.01% 896
2023
Q3
Sell
-2,429
Closed -$228K 947
2023
Q2
$228K Buy
+2,429
New +$189K ﹤0.01% 772

Other funds holding EXAS

IEQ Capital's EXAS Position: Q1 2026 in Review

IEQ Capital sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 303,816 shares — an estimated $30.9M sold.

IEQ Capital first reported a position in EXAS in Q2 2023 and held it in 7 quarters. The position peaked at $30.9M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • IEQ Capital reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • IEQ Capital sold 303,816 Exact Sciences shares in Q1 2026, an estimated $30.9M.
  • IEQ Capital first reported a position in Exact Sciences in Q2 2023 and held it in 7 quarters.
  • IEQ Capital's Exact Sciences position peaked at $30.9M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.